Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-199-9 | CAS number: 79-36-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No GLP and no guideline was followed.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 987
Materials and methods
Test guideline
- Guideline:
- other: no data
- Principles of method if other than guideline:
- No specific test guideline was reported; however, a scientifically defensible approach was used to conduct the study.
Male rats were approximately 9-10 weeks old and weighed 325±16.8 g at study start. Food and water were provided ad libitum except during inhalation exposures.
Test atmospheres were generated by passing an airstream over the liquid test substance in a generating flask and then feeding the effluent vapor into the chamber air supply. Animal exposures were done in 1.0 m3 or 1.3 m3 dynamic exposure chambers. Chamber concentrations were measured periodically throughout the exposure and analyzed via an infrared gas analyzer.
All animals were observed daily and weighed monthly. All animals were allowed to die spontaneously or were sacrificed when moribund. Complete necropsies were performed at sacrifice. Nasal passages, brain, lung, trachea, larynx, liver, kidney, testes, and any other organs exhibiting gross pathology were examined microscopically. - GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Dichloroacetyl chloride
- EC Number:
- 201-199-9
- EC Name:
- Dichloroacetyl chloride
- Cas Number:
- 79-36-7
- Molecular formula:
- C2HCl3O
- IUPAC Name:
- 2,2-dichloroacetyl chloride
- Details on test material:
- - Name of test material (as cited in study report): Dichloroacetyl chloride
- Physical state: liquid at room temp.
- Analytical purity: more than 95%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- 9-10 week old male rats. The animals were quarantined for two weeks before the experiment.
TEST ANIMALS
- Source: Charles River breeding Laboratories, Wilmington, MA
- Age at study initiation: 9-10 weeks
- Weight at study initiation: 325g+/-16.8g
- Acclimation period:2 weeks of quarantine, during this time complete serologic and pathologic analyses were done on randomly selected animals, these analyses were found to be negative.
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Remarks on MMAD:
- MMAD / GSD: Exposure concentrations (mean +/-SD):
0.53+/-0.03
1.03+/-0.08
2.00+/-012 - Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: dynamic exposure chambers 1.0 and 1.3 m3, exposure was for 30 days (6 hours/dayx5 days/week)
- Method of holding animals in test chamber:
- Method of conditioning air:by varing the flow of air through the flasks, stable chamber concentrations were achieved
- System of generating particulates/aerosols: airstream passing over the liquid in a generating flask and then feeding the effluent vapor into the chamber air supply.
- Temperature, humidity, pressure in air chamber: room temperature
TEST ATMOSPHERE
- Brief description of analytical method used: infrared gas analyzer ( Wilkis Scientific Corp. South Norwalk, CT) - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Chamber concentrations of chemicals were analyzed at half-hour intervals during the daily exposures by means of Wilkis Miran infrared gas analyzer with the use of appropriate wavelenght for the compound.
- Duration of treatment / exposure:
- 30 days of exposure
- Frequency of treatment:
- 6 h/d, 5 d/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 0.5, 1, 2 ppm
Basis:
no data
- No. of animals per sex per dose:
- 50 animals / group
- Control animals:
- yes
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: No data
DETAILED CLINICAL OBSERVATIONS: daily observation
BODY WEIGHT: monthly weight control - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes , histologic sections were taken from each lobe of the lung, and from trachea, larynx, liver kidneys, testesand any other organs exhibiting gross pathology.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- effects observed, treatment-related
- Details on results:
- No mortality observed. At the highest dose group, after the appropriation 794 days, occurred in 2 animals nasal tumors (incidence: 4%), in the
Control group and the dose groups up to 1 ppm did not reveal any tumors.
Effect levels
- Effect level:
- 2 ppm
- Sex:
- male
- Basis for effect level:
- other: no mortality observed
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The authors suggest that dichloroacetyl chloride, due to very rapid hydrolysis cannot target DNA of nasal mucosa cells.
Applicant's summary and conclusion
- Conclusions:
- No mortality observed at tested doses.
- Executive summary:
In the study, at tested doses of 0.05, 1.00 and 2.00 ppm, no mortality was observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
